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Abstract
Surfactant protein B is a small homodimeric protein that is found tightly associated with surfactant lipids in the alveolar
space. In this review, we discuss the actions of SP-B on phospholipid membranes using information predominantly obtained
from model membrane systems. We try to correlate these model actions with current concepts of SP-B structure and
proposed biological functions. These functions may include critical roles in the intracellular assembly of surfactant through a
role in lamellar body organogenesis, the structural rearrangement of secreted surfactant lipids into tubular myelin, and the
subsequent rapid insertion of secreted surfactant phospholipids into the surface film itself. The relevance of SP-B to human
biology is emphasized by the fatal respiratory distress that is associated with a genetic deficiency of SP-B and the important
role of SP-B in certain exogenous surfactant formulations in wide clinical use. ß 1998 Elsevier Science B.V. All rights
reserved.
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1. Introduction
It has been known for many years that a mixture
of phospholipids dominate the composition of sur-
factant. Current models for the activity of surfactant
at the air^liquid interface in the lung ascribe a central
role to a speci¢c phospholipid, dipalmitoylphospha-
tidylcholine (DPPC), but these models also allow for
other components in regulating the properties of the
alveolar surface (see Chapter I by Goerke in this
issue for review). As analytic techniques have im-
proved, the list of these additional components has
grown and it is likely that even today the complete
recipe of pulmonary surfactant is unknown. In recent
years, the focus of much investigation has been the
discovery, description, and study of surfactant asso-
ciated proteins or apoproteins (reviewed in [1,2]).
This review will focus on just one of these apopro-
teins, SP-B, with a description of protein structure
and the actions of SP-B on surfactant lipid mem-
branes. In a focused review of this kind, it is some-
times easy to forget that the surfactant components
act as players in an orchestra with no soloists. De-
scriptions of a single component inadequately de-
scribe the whole and other contributions in this issue
should be consulted for more complete coverage of
the biology of SP-B and its role in the surfactant
system.
King et al. reported the presence of surfactant-as-
sociated hydrophobic proteins in the ¢rst signi¢cant
study of surfactant apoproteins in 1973 [3]. Further
characterization of the hydrophobic proteins associ-
ated with lamellar bodies, probably including the
¢rst description of the protein now called SP-B,
was contributed by Phizackerley and colleagues
four years later [4]. The number and signi¢cance of
these proteins remained uncertain until improved an-
alytic techniques allowed unambiguous separation of
the hydrophobic surfactant apoproteins, both from
each other and from the more abundant and more
hydrophilic apoprotein SP-A [5]. In 1987, the cDNA
and gene for SP-B were cloned in several species to
¢nally allow de¢nitive codi¢cation of the hydropho-
bic surfactant apoproteins [6^8]. Numerous studies in
the decade since have been undertaken to understand
the nature of the interactions between SP-B and sur-
factant lipids and to decipher its role in lung func-
tion. Several actions on membranes have been de-
scribed, but it is fair to say that no coherent
molecular mechanism of action has been put for-
ward. There is not even a current consensus as to
the nature of the interactions between SP-B and lip-
ids or the other surfactant proteins. This is perhaps
not too surprising given the general di⁄culties in
studying proteins in membranes and in directly as-
cribing an e¡ect on membrane organization with a
speci¢c biological activity. In this review, we have
attempted to summarize themes emerging from stud-
ies of SP-B structure and membrane activity. In the
spirit of this issue, we have allowed ourselves to both
speculate on the possible signi¢cance of these obser-
vations and to point out some of the critical ques-
tions still to be answered. Readers are encouraged to
maintain a healthy scepticism to some of the person-
al interpretations provided here.
2. The structure of SP-B
2.1. Preproprotein organization and processing
SP-B isolated with surfactant obtained by lung
lavage is a 79 amino acid homodimer of approxi-
mately 18 kDa [7]. The SP-B gene is ¢rst tran-
scribed/translated into a signi¢cantly larger mono-
meric preproprotein of approximately 42 kDa. The
intracellular processing of this monomeric precursor
into the secreted dimeric form of SP-B is described in
detail by Weaver (see Chapter VII) in this issue and
will only be brie£y outlined here to provide context
for what follows. The proprotein is N-glycosylated
on regions £anking the mature SP-B sequence. These
£anking arms are cleaved in at least two steps to
release the mature from of SP-B [9^11]. The pro-
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teases involved are unknown but SP-B processing is
completed in compartments that lie between the
trans-golgi and the lamellar body, perhaps primarily
in the abundant multivesicular body and transitional
composite body compartments immediately proximal
to lamellar bodies in the secretory pathway of type II
cells [12].
The human proprotein contains 22 cysteines. The
repeating periodicity of these residues can be used to
schematically arrange the proprotein into three tan-
dem repeats, each 80^90 amino acids in length. These
repeats de¢ne the amino and carboxy terminal £ank-
ing domains and the mature protein itself (Fig. 1A).
The proprotein, presumably containing 10 intrachain
disul¢de bonds and two free cysteines, is a monomer
in type II cells. The major processing intermediates
in type II cells are also monomers, suggesting the
single interchain disul¢de at Cys-248 responsible for
dimerization of the mature form of SP-B [13] does
not form until after the cleavage of the proprotein is
complete [9]. Based on the conserved cysteine peri-
odicity and pattern of conserved hydrophobic resi-
dues (see Section 2.3 and Fig. 1C), it is reasonable
to think the tertiary fold of the £anking arms and
mature SP-B may be similar. The speci¢c amino acid
sequences of the £anking arms are however readily
distinguished from mature SP-B. In particular, the
charge density and distribution di¡ers signi¢cantly.
The amino- and carboxy-terminal domains are both
anionic with net charges of 34 and 32, respectively,
in contrast to the strongly cationic pro¢le (+7) of
mature SP-B. The sequences linking the £anking do-
mains to mature SP-B are rich in the structure break-
ing residues, proline and glycine, and are less tightly
conserved between species. They are probably lo-
cated on the protease-exposed surface of the propro-
tein and likely serve as loosely structured connections
between mature SP-B and the two £anking arms [14].
The function of the £anking sequences has not
been established. It is possible that the more hydro-
philic £anking domains surround the internalized hy-
drophobic mature protein in the folded proprotein
and protect cell membranes from its destabilizing
lytic activity until it is compartmentalized with sur-
factant lipids in the multivesicular body or lamellar
body (see Section 3.2). It is also possible that the
£anking domains have biological activities of their
own before or after release from the proprotein. Nei-
ther of these hypotheses has been tested. A major
ongoing challenge in this area is to develop function-
al and e⁄cient heterologous expression systems for
SP-B. Correct refolding of mature SP-B in vitro has
not been reported but recent progress towards heter-
ologous expression of SP-B proprotein gives hope
that experimental systems suitable for the testing of
structure^function hypotheses will be forthcoming
[15].
2.2. Amino acid sequence and models of secondary
structure
Although the sequence of mature SP-B, the homo-
dimer found with surfactant in lamellar bodies and
the extracellular alveolar space, is generally more
Fig. 1. Schematic representation of the SP-B preproprotein and mature SP-B. (A) The SP-B preproprotein (residues 1^381) with the
signal peptide as a shaded box and the three saposin-like domains of the proprotein as ovals. (B) The mature form of SP-B (residues
201^279 of the proprotein) with the ¢ve predicted helices placed as per the NK-lysin structure [21]. (C) The consensus sequence de¢n-
ing the saposin-motif showing the periodicity of the six conserved cysteines and the location of the conserved hydrophobic residues
(X) (modi¢ed from [21]). The disul¢de bonds are as described for SP-B [13] and NK-lysin [21]. The location of the intermolecular di-
sul¢de unique to mature SP-B is marked by an arrowhead in B.
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hydrophobic than the £anking arms, no run of con-
secutive hydrophobic sequence suggestive of a trans-
membrane domain is present. If however, short re-
gions of the protein are arranged in an K-helical
con¢guration the skewed distribution of polar and
non-polar residues characteristic of amphipathic heli-
ces becomes apparent. Although several models have
been proposed, the exact start and stop boundaries
of these helices have not yet been determined. In the
model proposed by Andersson and colleagues [16],
four amphipathic helices, bounded by residues 8^
22, 27^38, 42^50, and 67^74 (where 1 is the amino
terminus of mature SP-B corresponding to 201 of the
human preproprotein), are aligned in an antiparrallel
left-handed ‘hair-pin’ like motif. The K-helical con-
tent predicted by this model is in reasonable agree-
ment with experimental data [16^20]. As discussed in
Section 2.3, this assignment is also in close agreement
with the solution structure of the homologous pro-
tein, NK-lysin [21].
The net secondary structure content does not
change appreciably when SP-B is lipid bound [20],
but it is quite likely that the tertiary and quaternary
structures are in£uenced by the polarity of the sol-
vent environment. Further work is required to more
accurately de¢ne the structural features of SP-B
when it is anchored to a lipid membrane. Human
SP-B has nine positive and two negative amino acids,
giving a net charge of +7. The charge density and
distribution in other species is similar. It is unknown
how these charged residues might be clustered by the
tertiary fold and therefore how the charged residues
might be arrayed relative to anionic phospholipid
head groups.
Each SP-B monomer contains three intramolecular
disul¢de bridges that link Cys-8^77, Cys-11^71, and
Cys-35^46 [13]. The remaining cysteine in SP-B at
position 48 forms the intermolecular bond responsi-
ble for dimerization. Dimerization does not occur
until cleavage of the £anking arms is complete, fur-
ther supporting a model of the proprotein wherein
the mature SP-B is compartmentalized in the propro-
tein interior. An interesting exception to this gener-
ally conserved organization may exist in the cow
where the isolated protein appears to assemble as a
disul¢de-dependent trimer [22]. The disul¢de linkages
presumably constrain the protein’s £exibility and
contribute to the remarkable thermal stability of
the secondary structure [16] and the unusual resist-
ance to both acid and proteolytic degradation. Inter-
estingly, the content of secondary structure is little
changed with reduction of the disul¢des [16]. The
importance, if any, of the disul¢des to function is
poorly understood, but recent work utilizing trans-
genic mice suggests a possible role for the intermo-
lecular bond in the correct packaging of phospho-
lipids into lamellar bodies [23].
2.3. Homologous tertiary structures: the shared
saposin motif
Sequence alignments have uncovered a family of
proteins that have in common with SP-B the same
periodicity of the six cysteine residues paired as di-
sul¢des and an additional set of nine hydrophobic
residues (reviewed in [21,24,25]). This family of sap-
osin-like proteins takes its name from the lysosomal
proteins, saposins A^D, the ¢rst proteins of this fam-
ily characterized. The four saposins are all cleaved
from a common precursor, proprotein organized
similarly to the SP-B proprotein. Other proteins
sharing the saposin motif include the T-cell cytolytic
protein, NK-lysin or its human homolog granulysin;
Entamoeba histolytica pore-forming proteins, the
amoebopores; and domains of human acid sphingo-
myelinase and acyloxyacylhydrolase. An interesting
variation of the saposin motif (‘swaposins’) has also
been identi¢ed in some plant aspartic hydrolases in
which the N-terminal and C-terminal halves of the
motif have been swapped. As is often the case for
proteins grouped by shared structural elements the
functions ascribed to the saposin-like family vary.
Saposins A^D are lysosomal proteins that bind gal-
actosyl- and glucosyl-ceramides and activate a num-
ber of lysosomal hydrolases. NK-lysin and amoebo-
pores both have antibacterial activity and are
cytotoxic to tumor cells at high concentrations [25].
The role of the saposin or swaposin motifs in human
and plant enzymes is at present unknown. Four of
the saposin-like proteins; saposin-C, SP-B, amoebo-
pore and NK-lysin bind to membranes enriched in
negatively charges phospholipids. Although the ac-
tivity of each protein varies, binding is followed by
lysis or fusion of the membrane in each case.
The NMR structure for NK-lysin has recently
been determined [21]. The structure con¢rms the gen-
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eral features of the SP-B model proposed by Anders-
son [16]. The strict conservation of key structural
residues in the saposin-like family suggests the gen-
eral features of the NK-lysin fold will be common to
all members of this family including SP-B. Caution
must obviously exercised in transposing the water-
soluble NK-lysin structure to SP-B, particularly as
SP-B stands out from the other saposin-like proteins
in being both water-insoluble and dimeric. Neverthe-
less, the NK-lysin structure signi¢cantly extends our
understanding of the folding topology adopted by
this family of membrane associated proteins. In
water NK-lysin folds as a single globular domain
with ¢ve amphipathic K-helices aligned to create
two cavities in the core lined by the conserved hydro-
phobic side chains of the helices. While this packing
allows the ¢ve amphipathic helices to form a water
soluble domain, it may not accurately represent the
relationship of the helices when NK-lysin binds lip-
ids.
The loops between helices and solvent exposed
residues are far less conserved between saposin-like
members. These more variable residues probably
confer binding and functional speci¢city. Even
though both SP-B and NK-lysin share a net positive
charge of +7 the charge distribution and density be-
tween helices are signi¢cantly di¡erent. Another ob-
vious sequence di¡erence between SP-B and NK-ly-
sin is the marked hydrophobicity of the loop between
helices 2 and 3 in SP-B. This loop, stabilized by the
Cys-35^46 disul¢de, is notably hydrophobic in SP-B
with 60% non-polar residues. A synthetic analog of
these 12 amino acids adopts a looped B turn in the
structure-promoting solvent tri£uoroethanol [26],
similar to the homologous region in the NK-lysin
structure. An attractive hypothesis put forward by
Waring and colleagues predicts this hydrophobic
turn element might dip into the interior of the lipid
bilayer anchoring and orienting the more bilayer sur-
face-associated amphipathic helices [26]. There is no
doubt that the available structure of NK-lysin repre-
sents a major extension of our knowledge concerning
the topology of the saposin motif and that it will
instruct further experimentation with SP-B. Unfortu-
nately, however, the structure of the water-soluble
form only incrementally adds to our understanding
of how the saposin-like proteins, in general, and SP-
B, in particular, might interact with lipids.
3. The actions of SP-B on membranes
In attempting to formulate a coherent model of
SP-B activity from the wide range of biophysical
studies reported to date, several limitations to these
experimental approaches must be carefully consid-
ered. First, there are inherent di⁄culties with direct
structural studies of membrane proteins in their lipid
environments and much of our current knowledge on
SP-B function comes from indirect kinetic studies
and structure^activity studies with synthetic analogs.
Second, a multiplicity of techniques, each operating
in di¡erent time domains and with di¡erent sensitiv-
ities, limitations, and assumptions, have been used in
the study of SP-B. Finally, it is by no means certain
that any or all of the many reported activities of
SP-B are directly related, or even relevant, to its bio-
logical functions.
Although a coherent description of the relation-
ship between SP-B structure and function therefore
still eludes us, a catalog of its multiple actions, either
alone or in cooperation with other surfactant pro-
teins, on membranes is growing. In no rank order
these activities include: membrane binding, mem-
brane lysis, membrane fusion, promotion of lipid
adsorption to air^liquid surfaces, stabilization of
monomolecular surface ¢lms, and respreading of
¢lms from collapse phases. Many apparent contra-
dictions in the experimental data remain to be re-
solved. A systematic resolution of these current con-
tradictions and a further step-wise quantitative
investigation of individual steps in the complex ac-
tion of SP-B on both bilayers and monolayers will be
required to reach the desirable goal of an under-
standing of SP-B biology at the molecular level.
3.1. Puri¢cation and experimental conditions
In all reconstitution systems a precise knowledge
of the purity of the reagents and the in£uence of the
conditions of protein isolation and protein^lipid re-
constitution are required. These requirements are
only partially met in most studies of SP-B and lipids.
Several methods have been developed to isolate SP-B
from lavaged surfactant. Variable contamination of
the ¢nal product with SP-C and trace amounts of
anionic phospholipids and glycolipids is di⁄cult to
avoid, but the degree of contamination or its poten-
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tial impact on results is often overlooked. All current
protocols require harsh conditions with exposure to
organic solvents and or acid and or detergent. Sig-
ni¢cant examples of possible deleterious e¡ects of
such exposures include the formation of solvent-spe-
ci¢c ester carbonyls [27] and the time- and temper-
ature-dependent cleavage acid-sensitive bonds in
SP-B [5]. Both modi¢cations may in£uence bio-
physical activity.
Similarly, the physical pathways followed during
reconstitution with lipids (detergent dialysis, sonica-
tion, extrusion, etc.), the component concentrations
and order of addition, and the aqueous solvent con-
ditions (pH, ionic strength, anion and cation concen-
tration and type, temperature, etc.) may all be major
determinants of results [28]. At this time, it is not
possible to proscribe ideal conditions and protocols
for the puri¢cation, storage and reconstitution of SP-
B but the possible in£uence of subtle variations in
each of these steps clearly must be considered in each
experiment.
3.2. SP-B action on preformed vesicles: a model of
lamellar body organogenesis
As an amphipathic cationic small protein SP-B
has, not surprisingly, a signi¢cant ‘detergent-like’ ef-
fect on preformed phospholipid liposomes. We have
broken down these e¡ects into discrete steps in an
e¡ort to model the complex processes occurring after
SP-B is released from the proprotein in near prox-
imity to lipid vesicles in the environment of the mul-
tivesicular body [29,30]. An important, but un-
proved, assumption here is that the mature form of
SP-B does not assemble with lipids until this cleavage
event occurs. For purposes of description and anal-
ysis, the process has been modeled according to the
mass-action scheme [29,30]. This model assumes a
rapid, essentially irreversible, binding of SP-B (B)
to the vesicle (V) to form a lipoprotein complex
(VB), reversible aggregation of VB complexes (A),
and ¢nally reorganization of the aggregated com-
plexes into an irreversible fused product (F):
V B63bsVB6d3csA3fsF 1
where b is the apparent surface partition coe⁄cient
(M31), c and d are the aggregation and disaggrega-
tion rate constants (M31 s31), and f is the fusion rate
constant (s31). This model makes no assumptions
about the physical form of the complexes or the mo-
lecular topology of the components involved. It does
serve as a basis for description and as a sca¡old for
attaching di¡erent biophysical observations and hy-
potheses. Kinetic measurements on the time scale of
seconds to minutes derived from £uorescence and
energy transfer studies can be supplemented with
spectroscopic studies operating in the millisecond
and below domain and more static morphological
studies to eventually build a more complete model
for SP-B activity.
3.3. SP-B membrane binding
SP-B binds rapidly to preformed large unilamellar
vesicle made from DPPC and varied amounts of
phosphatidylglycerol (PG). The apparent binding af-
¢nity increases linearly with the amount of PG
present. SP-B binds vesicles containing 30% PG, a
composition shown to sustain approximate morpho-
logical and functional reconstitution of surfactant,
with an apparent surface partition coe⁄cient of
2.7U107 M31 [31]. Fluorescence self-quenching of
the bound SP-B is detectable when only approxi-
mately 3% of the roughly 600 potential binding sites
per vesicle are occupied. This result suggests that
essentially irreversible aggregation or oligomerization
of SP-B may rapidly occur in a lipid environment
[31]. This lipid-driven aggregation does not appear
to be associated with a large change in secondary
structure as the overall content of K-helix, L-sheet
and turns is similar in organic solvents [20], detergent
micelles [16], lipid bilayers [19], and lipid monolayers
[18]. As discussed in Section 2.3, the tertiary or qua-
ternary conformation adopted by SP-B in a lipid
membrane is not known. Current challenges in this
area are to determine if this oligomerization is re-
quired for activity, has a precise stoichiometry, and
is regulated by speci¢c features of the lipid environ-
ment.
3.4. SP-B-dependent membrane lysis and fusion
Membrane binding does not alter vesicle integrity,
as detected by a release of vesicle contents, until
there is aggregation of the lipid-bound SP-B [31].
Thereafter, a graded dose-dependent loss of vesicle
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contents begins (Fig. 2), suggesting increasing perme-
abilization of the vesicle membrane and loss of
vesicle integrity [29^31]. We have not been able to
detect any evidence for pore-formation in these ex-
periments even at low SP-B concentrations. The de-
stabilizing e¡ects on vesicle membranes are again
markedly sensitive to the PG content. The permeabi-
lization of membranes by SP-B is associated with a
dramatic morphological rearrangement of the vesic-
ular structure [34,53]. At relatively high SP-B con-
tents (0.5^1 M%) the vesicle embranes are broken
down into small bilayer discs. SP-B molecules prob-
ably line the disc edges protecting the acyl chains
from interactions with water [34]. Similar ‘bicycle-
tire’ structures have been observed with saturated
phosphatidylcholines and other amphipathic proteins
and peptides [32].
These small, regularly sized discs rapidly fuse
under isothermal conditions [29,33] to generate large
membranous sheets that assemble into multilayered
stacks with minimal interbilayer space [34]. Kinetic
analysis indicates the fusion rate constant varies de-
pending on the membrane phospholipid composi-
tion, but that for any given composition the rate of
fusion is strictly dependent on the SP-B concentra-
tion [30]. It is possible, as suggested by Johansson
and Curstedt [1], that the dimeric nature of SP-B
may allow it to bring two lipid bilayers in close prox-
imity. Consistent with this idea, regularly spaced ar-
rays maintaining the original dimensions of the lipo-
protein discs and presumably representing SP-B
aggregates are visible in these membrane stacks by
both thin section and negative stain electron micro-
scopy [34]. It is tempting to postulate that these
events: SP-B vesicle binding, leading to protein ag-
gregation in the plane of the bilayer, leading to
vesicle disruption and the formation of large closely
stacked sheets of bilayer membranes containing
highly ordered arrays of oligomerized SP-B, is a
model for the organogenesis of the lamellar body
(Fig. 3). Certainly, mice lacking SP-B seem unable
to normally convert multivesicular body vesicles to
organized lamellae [35]. The morphological correla-
tions are reasonable but much more experimentation
is required to validate the system as a reasonable
model of such a complex event. Questions in this
area include: the e¡ects of aqueous conditions that
Fig. 2. SP-B binding, surface aggregation, vesicle permeabiliza-
tion and vesicle fusion as a function of the SP-B/phospholipid
molar ratio (adapted from [31] with permission). The phospho-
lipids were a 7:3 mixture of DPPC and phosphatidylglycerol
prepared as large unilamellar liposomes. Binding, SP-B aggrega-
tion, permeabilization, and fusion were measured by £uorescent
techniques [31]. Filled circles, SP-B binding expressed as num-
ber of SP-B dimers bound per vesicle (top X axis). Crosses, ag-
gregation of the membrane-bound SP-B. Open circles, permea-
bilization of vesicles as determined by leakage of soluble vesicle
contents. Filled triangles, membrane fusion as determined by
energy transfer between membrane-associated probes. See [29^
31] for methodological details.
Fig. 3. A model for the actions of SP-B on surfactant lipids.
The top panel depicts intracellular events in type II cells and
the bottom panel depicts extracellular events. The potential sites
of SP-B action are indicated to the left of the cartoon. Mature
SP-B is represented by the small ¢lled squares. Bilayers are de-
picted as thick circles or lines and the surface monolayer as a
thin line. The letter A represents SP-A in tubular myelin.
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might be encountered in the multivesicular body and
lamellar body, the in£uence of other surfactant mem-
brane lipids on the process, and the e¡ects of speci¢c
SP-B structural elements such as Cys-48 and speci¢c
basic residues on the structure of the ¢nal fusion
product.
3.5. Topology of SP-B in bilayers
The unknown and probably changing topology of
SP-B to the vesicle membranes during these events is
probably the biggest hurdle to our further under-
standing of SP-B activity. A number of investigators
have concluded that SP-B is located mainly in the
super¢cial parts of the bilayer with only the apolar
helical faces and perhaps the apolar loop between
Cys-35 and Cys-46 [26] interacting with the acyl
chains in the region of the head groups without sig-
ni¢cant e¡ects deeper in the bilayer. This model, em-
phasizing super¢cial head group interactions, is
based primarily on the lack of an obvious transmem-
brane domain in the sequence, the ¢nding that 20^
40% of the helical segments align themselves parallel
to the bilayer plane, and the minimal perturbations
of acyl chain order sensed by both £uorescent aniso-
tropy and Fourier transform infrared spectroscopy
[17,19]. Certainly, at low SP-B content and with
gel-phase lipids little e¡ect on acyl chain order and
dynamics has been detected with any technique. At
higher SP-B contents a signi¢cant, but still modest,
e¡ect on acyl chain ordering is seen with £uid phase
lipids by both electron spin resonance [36] and mag-
netic resonance spectroscopy [37]. This result infers a
slight reduction in area per lipid and is hard to rec-
oncile with a substantial insertion of regions of SP-B
into the headgroup region which should increase area
per lipid [38]. An alternate model wherein SP-B is
oriented around the edges of bilayer discs would be
consistent with these results. Both models allow for
preferential lipid^protein complex stabilization by
electrostatic interactions between anionic phospholi-
pid head groups and the basic residues in SP-B, for
the unexpectedly large number of lipid molecules ap-
parently perturbed by a single molecule of SP-B
[36,39], and a primarily parallel orientation of the
helices with the bilayer plane [19].
Taken together, these studies suggest the SP-B lip-
id stoichiometry may be an important determinant of
the speci¢c e¡ect of SP-B on the organization of lipid
bilayers. It seems at least worth considering that the
topology of SP-B to the bilayer changes as a function
of the lipid^protein ratio, and therefore, possibly as a
function of lamellar body maturation. Initial primar-
ily super¢cial surface association at low SP-B con-
centrations might be followed by micellization and
disc formation as the protein content rises. As discs
form SP-B presumably rings the disc edges giving the
apolar residues of SP-B greater access to the acyl
chains. As the discs fuse SP-B must redistribute in
the plane of the forming membrane sheets. Con-
trolled oligomerization of SP-B and preferential in-
teractions with anionic phospholipids could facilitate
long-range segregation of phospholipid domains, a
phenomenon potentially important for events subse-
quent to lamellar body secretion. The dimeric struc-
ture of SP-B would allow it to cross-link discs within
the plane of the bilayer or cross-link closely apposed
fused membrane sheets setting up the sca¡old for the
transition of lamellar body contents into tubular
myelin (see Section 3.5). Obviously a detailed under-
standing of the molecular mechanisms underlying
SP-B activity awaits determination of its conforma-
tion in membranes, its location and orientation with-
in the bilayer and its self-association properties. A
further factor warranting study is a determination
of the actual stoichiometry of SP-B to lipid in di¡er-
ent surfactant pools and structures. This last point
has received little attention to date, but the available
data suggests a bulk lamellar body content of at least
0.01^0.05 M% [40]. Whether higher local concentra-
tions are achieved in structures, such as the lamellar
body core or crystalline arrays, is unknown.
3.6. Interactions of SP-B with SP-A: a role in tubular
myelin formation
SP-B is a necessary, but not su⁄cient, protein for
the formation of tubular myelin, the complex three-
dimensional tubular structure formed after secretion
of the lamellar body contents into the alveolar space
[34,53]. The function of this fascinating structure is
uncertain. Indeed, its biological signi¢cance has been
questioned after discovering that genetically modi¢ed
mice lacking tubular myelin have apparently normal
lung function (see Chapter XVI by Korfhagen in this
issue). Nonetheless the observation that tubular mye-
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lin formation and/or stability is dependent on inter-
actions between SP-B and SP-A both in vitro [34,53]
and in vivo [35,41] emphasizes the potential for in-
teractions between SP-B and components other than
phospholipids. At this time, it is uncertain if the co-
operativity between SP-B and SP-A in phospholipid
reorganization is a result of direct protein^protein
interactions or secondary to more distant e¡ects
mediated through alterations of lipid structure. The
fact that other fusigenic proteins, such as mellitin,
cannot substitute for SP-B in the synergistic activity
with SP-A suggests the former, but direct proof is
lacking [29,30]. Similarly, other members of the sap-
osin-like family of proteins are involved in multicom-
ponent interactions, notably the interactions between
the saposins, lysosomal hydrolases and glycolipids,
without a clear picture of the relative contributions
of protein^protein and protein^lipid interactions.
3.7. SP-B monolayer studies: a model for
extracellular SP-B function
The subject of the interfacial properties of the sur-
factant proteins is covered in depth by Keough and
Perez-Gil in this issue (see Chapter XVI) and will
only be brie£y reviewed here. SP-B clearly enhances
the rate of adsorption of phospholipids from an
aqueous subphase to an air^water interface. The im-
portance of this process to lung mechanics is dis-
cussed in detail by Goerke in Chapter I of this issue.
SP-B enhanced phospholipid adsorption has been re-
peatedly demonstrated under both quasi-equilibrium
and dynamic conditions [5,7,42,43], but the mecha-
nisms are still poorly understood. The reconstitution
pathway followed during sample preparation and the
¢nal physical state of the sample seem to be partic-
ularly important in determining the magnitude of the
enhancement seen. Well-annealed samples generally
show less activity. This observation suggests ‘hot
spots’ or packing inhomogeneities induced by SP-B
might be important in adsorption, but little has so
far been done to directly address the mechanisms
involved.
Most studies in this area have examined adsorp-
tion to a clean air^water interface. In life, this con-
dition probably only applies to the ¢rst breath with
all subsequent adsorption being to an already parti-
ally lipid-occupied interface. Innovative studies by
Oosterlaken-Dijksterhuis and colleagues have shown
that SP-B in a preformed interfacial ¢lm is particu-
larly e¡ective in promoting further adsorption of
phospholipid [18,44]. We have also observed that
the dose^response curves for SP-B-dependent phos-
pholipid adsorption rate and SP-B-dependent mem-
brane fusion rate essentially overlie each other sug-
gesting, perhaps, common mechanisms for these two
actions of SP-B. The full e¡ects of complex interac-
tions between phospholipid charge and £uidity,
anion concentrations, pH, and bilayer strain on these
activities still need to be explored. The actual com-
position and morphology, monolayer versus multi-
layers, of the air^water interface in the lung remains
to be determined, but in vitro work suggests SP-B
can occupy a surface to quite high pressures. The
available data suggests SP-B retains its K-helical con-
tent when spread on an interface with or without
phospholipid [18]. The pure protein ¢lm so formed
is extremely stable with a collapse pressure of 36 mN
M31. At this pressure the calculated area per residue
is 0.16 mm2, assuming all residues of the dimer are in
the interface [18]. The close agreement between this
value and the number obtained for other simple am-
phipathic helices suggests SP-B adopts an extended
conformation with almost all of the residues in the
plane of the interface and that considerable £exibility
in this conformation is tolerated as the surface pres-
sure is changed. How this surface orientation might
be perturbed in the presence of lipid is unknown.
Keough and colleagues have extended these studies
by making dynamic cyclic surface pressure-area
measurements [45] and matrix-assisted laser desorp-
tion/ionization spectroscopy (MALDI) measure-
ments [46] on ¢lms containing SP-B and phospholip-
ids. They ¢nd most SP-B is retained in mixed ¢lms
to surface pressures as high as 43 mN M31 and some
is maintained in patches of expanded £uid phase lip-
id to even higher pressures. Importantly, the SP-B
and associated lipid is rapidly redispersed in the in-
terface from collapse phases when the ¢lm is re-ex-
panded. This suggests multiple potential sites of SP-B
activity in the alveolar space including the three-di-
mensional bilayer structures adopted by freshly se-
creted surfactant, the interfacial ¢lm itself, and col-
lapse phases perhaps closely adherent to the
interfacial ¢lm (Fig. 3). The roles for SP-B in alveo-
lar surfactant dynamics might include the initial for-
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mation of an interfacial ¢lm from secreted surfactant
complexes and the replenishment of a preformed ¢lm
during respiration by either enhanced adsorption or
respreading from collapse phases. It is likely that
lessons learned on the molecular actions of SP-B
from the study of interacting bilayers (see Sections
3.4 and 3.5) will be also be relevant to the interac-
tions between bilayers and monolayers.
3.8. SP-B peptide studies
Traditional structure^activity studies employing
site-speci¢c mutation of residues in SP-B have so
far been hampered by di⁄culties in heterologous ex-
pression of a correctly folded form of SP-B and by
di⁄culties in folding full length synthetic SP-B pep-
tides. The reasons for this di⁄culty undoubtedly lie
in the hydrophobicity of the protein and the high
cysteine content leading to non-speci¢c aggregation
and incorrect disul¢de pairing respectively. Because
of these di⁄culties considerable e¡ort has gone into
designing peptide analogs based on short segments of
SP-B sequence. The major emphasis of these studies
to date has been to identify minimal regions of the
protein retaining the interfacial properties thought to
be important for exogenous surfactant activity [47^
51]. The most detailed analysis has focused on resi-
dues 1^25, presumed to consist of a short N-terminal
extension and all of the ¢rst cationic, amphipathic
helix in the mature protein. This peptide spontane-
ously adopts an K-helical structure and studies with
monolayer ¢lms of palmitic acid indicate it can sta-
bilize such ¢lms at high surface pressures [48] and
promote reversible respreading on expansion [47].
These studies are consistent with the notion that
the amphipathic structure and speci¢c charge inter-
actions between cationic residues and anionic lipids
are important to ¢lm stabilization, but much remains
to be done to determine if peptide-based studies are
accurately modeling the behavior of native SP-B.
The sequence speci¢city required to achieve specif-
ic interfacial e¡ects is not known, nor is it clear how
behavior in a variety of biophysical assay systems
correlates with in vivo performance. These unan-
swered questions are obviously of clinical and com-
mercial importance. The ¢rst real test of the idea that
a peptide analog might adequately substitute for the
more complex surfactant proteins is under way with
KL4, a model 21 residue peptide loosely based on the
¢rst helix of SP-B [51].
4. Summary
It has been 40 years since the ¢rst descriptions of
pulmonary surfactant [52] and almost 20 years since
the ¢rst description of the protein now called SP-B
[4]. Considerable progress in our understanding of
the biology of this protein has occurred in this inter-
val, but it seems, at least to us, that our understand-
ing of SP-B gene regulation and cell processing has
outstripped our fundamental understanding of what
the protein does and to an even greater extent how it
does it. Discovery of the importance of SP-B to sur-
factant replacement formulations and more recently
the painful example of infants born with a genetic
de¢ciency of SP-B (see Chapter XIX by Nogee in
this issue) provides ample incentive for investigators
to redress this perception. The coalescence of high-
resolution structural data and the creation of expres-
sion systems and mouse models to test structure^
function hypotheses should provide the tools.
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